John L. Dzuris0000-0002-0046-8426
John L. Dzuris received his B.S. degree in microbiology in 1983 from the Ohio State University, Columbus, OH, USA, and in 1987 received his M.S. degree in microbiology from Louisiana State University, Baton Rouge, LA, USA. He then attended Temple University School of Medicine in Philadelphia, PA, USA, receiving his Ph.D. degree in 1994 from the Department of Microbiology and Immunology, concentrating his studies on retroviral escape from host immune responses. In his postdoctoral training, he continued his study on retroviral and host immune response interactions, which was completed at the Department of Microbiology, Pennsylvania School of Medicine, Philadelphia, PA, USA. Dzuris then joined the staff at Epimmune, Inc., San Diego, CA, USA, in 1998, where he worked to develop DNA and peptide based vaccines for oncology and infectious diseases and determined similarities existing between human and nonhuman primate immune responses for use as a model for preclinical evaluation of vaccine efficacy. In 2001, he joined the staff at Wyeth Corporation as a Senior Scientist at the Department of Viral Immunology, Pearl River, NY, USA, conducting viral vaccine discovery research. Dzuris was then recruited to join Genzyme Corporation, Cambridge, MA, USA, in 2002 as a Senior Scientist to help discover and develop vaccines for oncology and infectious diseases. Spending nearly 10 years at Genzyme, Dzuris led the Cellular Immunology Group as an Associate Director in discovery research identifying biotherapeutics and small molecule drugs for oncology, transplant, and autoimmune disease. He currently serves as the Director of Immunology at ImmusanT, Inc., Cambridge, MA, USA, evaluating immune responses to a potentially tolerizing peptide‐based immunotherapeutic vaccine for celiac disease.
Biography Updated on 27 September 2014